Health Catalyst (HCAT): Director received 5,731 shares

5,731

Shares

Traded

Dec 1, 2025

Filed

Dec 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
2. Dec 1, 2025Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement (and 1 more item)“On December 1, 2025, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Matt Arens to the Board, effective December 1, 2025.”

What came next

1. Dec 4, 2025InsiderDirector sold ~$128K of HCAT shares in the open market
2. Dec 5, 2025InsiderOfficer sold ~$72K of HCAT shares in the open market
3. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
4. Jan 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 20, 2026, the Board of Directors of Health Catalyst, Inc. (the Company) determined that Kevin Freeman will cease to serve as the Chief Commercial Officer of the Company on February 1, 2026.”
5. Feb 12, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 12, 2026, the Board of Directors (the Board) of Health Catalyst, Inc. (the Company) appointed Ben Albert to succeed Mr. Burton as the Company’s Chief Executive Officer and principal executive officer, effective February 12, 2026.”
6. Mar 12, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Health Catalyst

For Health Catalyst, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCAT page.

Other recent filings by Julie Larson-green, Director

• SEC Form 4 at Health Catalyst (HCAT)Dec 10, 2025

The full history of Julie Larson-green, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Health Catalyst

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 144Nov 12, 2026
• SEC Form 144Nov 11, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Dec 10, 2025

Everything OQRO holds on this company is on its HCAT page.